Johnson & Johnson (NYSE:JNJ) recently announced the election of Daniel Pinto, a seasoned executive with extensive experience, ...

Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of ...

Johnson & Johnson (NYSE: JNJ) announced today that it elected JPMorganChase President Daniel Pinto to its board of directors.

Ethicon 4000 features proprietary 3D staple technology, a redesigned end effector and streamlined reload options. Johnson & ...

Early Phase I results for JNJ-79635322 demonstrated an 86.1% overall response rate in heavily pretreated multiple myeloma ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple ...

Johnson & Johnson shows strong profitability and solid value, but faces growth uncertainty, legal risks, and pricing ...

All right, thank you, everybody. Thanks, guys. I'm Lee Hambright, US MedTech Analyst at Bernstein, and we are thrilled to host Johnson & Johnson. We have Chairman and CEO, Joaquin Duato and CFO ...

Leerink Partners downgraded their outlook for Johnson & Johnson (NYSE:JNJ) from Outperform to Market Perform. Analyst Price Forecast Suggests 17.34% Upside As of May 7, 2025, the average one-year ...